Rose Parkinson

Research Associate

20052019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Rose Parkinson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
DNA Vaccines Medicine & Life Sciences
Plasmids Medicine & Life Sciences
Interleukin-15 Medicine & Life Sciences
Macaca Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Simian Immunodeficiency Virus Medicine & Life Sciences
irinotecan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

A phase i trial of the VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced solid tumors and differentiated thyroid cancers

Kurzrock, R., Ball, D. W., Zahurak, M. L., Nelkin, B. D., Subbiah, V., Ahmed, S., O'Connor, A., Karunsena, E., Parkinson, R., Bishop, J. A., Ha, Y., Sharma, R., Gocke, C., Zinner, R., Rudek-Renaut, M., Sherman, S. I. & Azad, N., Sep 15 2019, In : Clinical Cancer Research. 25, 18, p. 5475-5484 10 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor
Mitogen-Activated Protein Kinase Kinases
Thyroid Neoplasms
Protein-Tyrosine Kinases
Neoplasms

A phase I trial of a guadecitabine (SGI-110) and irinotecan in metastatic colorectal cancer patients previously exposed to irinotecan

Lee, V., Wang, J., Zahurak, M., Gootjes, E., Verheul, H. M., Parkinson, R., Kerner, Z., Sharma, A., Rosner, G., De Jesus-Acosta, A., Laheru, D., Le, D., Oganesian, A., Lilly, E., Brown, T., Jones, P., Baylin, S. B., Ahuja, N. & Azad, N., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6160-6167 8 p.

Research output: Contribution to journalArticle

irinotecan
Colorectal Neoplasms
Intercellular Signaling Peptides and Proteins
Fever
Gastrointestinal Neoplasms

Systematic review of intravenous ascorbate in cancer clinical trials

Nauman, G., Gray, J. C., Parkinson, R., Levine, M. & Paller, C., Jul 12 2018, In : Antioxidants. 7, 7, 89.

Research output: Contribution to journalReview article

Chemotherapy
Ascorbic Acid
Clinical Trials
Neoplasms
Drug Therapy

Egr3 induces a Th17 response by promoting the development of γδ T cells

Parkinson, R., Collins, S. L., Horton, M. & Powell, J., Jan 24 2014, In : PLoS One. 9, 1, e87265.

Research output: Contribution to journalArticle

T-cells
T-lymphocytes
T-Lymphocytes
Growth
mice

Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo

Kutzler, M. A., Kraynyak, K. A., Nagle, S. J., Parkinson, R., Zharikova, D., Chattergoon, M. A., Maguire, H., Muthumani, K., Ugen, K. & Weiner, D. B., Jan 2010, In : Gene Therapy. 17, 1, p. 72-82 11 p.

Research output: Contribution to journalArticle

Chemokine CCL27
DNA Vaccines
Antibody Formation
Immunity
Plasmids